Dr Andrew Brockway's panel, 'Clinical Trials in Australia: Performance, Competitive Advantages, Challenges and Evolving Policy' at AusBiotech 2024
Dr Andrew Brockway's panel, 'Clinical Trials in Australia: Performance, Competitive Advantages, Challenges and Evolving Policy' at AusBiotech 2024
Highlighting the vital work of Doherty Clinical Trials and sharing why participants find it so rewarding.
Delving further into the Doherty Clinical Trials experience and the purposes of human challenge trials, the article is another feature highlighting the company’s launch.
Receive up to $500 in rewards every time a friend completes their first Doherty Clinical Trials study.
Dr Andrew Brockway's panel, 'Clinical Trials in Australia: Performance, Competitive Advantages, Challenges and Evolving Policy' at AusBiotech 2024
Highlighting the vital work of Doherty Clinical Trials and sharing why participants find it so rewarding.
Doherty Clinical Trials launches the #mRNA Platform Incubator Network in collaboration with Moderna and other leading minds in bio-medical research
Delving further into the Doherty Clinical Trials experience and the purposes of human challenge trials, the article is another feature highlighting the company’s launch.
Launched by Deputy Premier, The Honourable Ben Carroll MP and Professor Sharon Lewin AO, Director of the Doherty Institute in East Melbourne.
If you would like to learn more about our clinical studies or discuss how we can help you achieve your clinical objectives, please contact us at:
Doherty Clinical Trials Ltd is an independent not-for-profit subsidiary of The University of Melbourne.